$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-009/20
  • A61K-009/14
  • A61K-009/48
출원번호 US-0546119 (2000-04-10)
발명자 / 주소
  • Lin, Henry C.
출원인 / 주소
  • Cedars-Sinai Medical Center
대리인 / 주소
    Sidley Austin Brown & Wood LLP
인용정보 피인용 횟수 : 101  인용 특허 : 26

초록

Disclosed are a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described

대표청구항

Disclosed are a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood flow. A method of treating visceral pain or visceral hypersensitivity in a human subject is also described

이 특허에 인용된 특허 (26)

  1. Kreutter David K. (Madison CT) Dow Robert L. (Waterford CT), b3-Adrenoceptor agonists and antagonists for the treatment of intestinal motilit.
  2. Balasubramaniam Ambikaipakan (Cincinnati OH), Analogs of peptide YY and uses thereof.
  3. Flynn Daniel L. (Mundelein IL) Moormann Alan E. (Skokie IL), Azanoradamantanes.
  4. Meyer James H., Composition and method for inducing satiety.
  5. Meyer James H., Composition and method for inducing satiety.
  6. Meyer James H. (2210 La Mesa Dr. Santa Monica CA 90402), Composition and method for inducing satiety.
  7. Asher William J. (Fanwood NJ) Vogler Tina C. (South Orange NJ), Detoxification by means of the controlled, in vivo secretion triggered rupture of liquid membrane capsules.
  8. Holman Hoi-Ying N., In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants.
  9. Urquhart John (Palo Alto CA) Theeuwes Felix (Los Altos CA), Intestine drug delivery.
  10. Kreek Mary J. (New York NY) Fishman Jack (New York NY), Method for controlling gastrointestinal dysmotility.
  11. Pedersen Arne M. (Vanlose DKX) Jensen Jens R. (Stenlose DKX), Method for preparing a pharmaceutical controlled release composition.
  12. Lin Paul M. ; Chang Shen-Youn ; Kruzel Chris, Method for providing nutrition to elderly patients.
  13. Bonsen Pieter (Los Altos CA) Wong Patrick S. (Kowloon CA HKX) Theeuwes Felix (Los Altos CA), Method of delivering drug with aid of effervescent activity generated in environment of use.
  14. Croom ; Jr. Warren J. ; Bird Anthony R.,AUX ; Taylor Ian Logan, Method of enhancing nutrient uptake.
  15. Bruno John F. ; White Jeffrey ; Berelowitz Michael ; Tripodi Daniel ; Heil Matthew, Method of regulating appetite and metabolism.
  16. Croom ; Jr. Warren J. ; Taylor Ian L. ; Coles Barbara A., Method of treating birds in ovo.
  17. Lin Henry C., Methods and compositions for improving digestion and absorption in the small intestine.
  18. Theeuwes Felix (Los Altos CA), Microporous-semipermeable laminated osmotic system.
  19. Bechgaard Helle (Hellerup DKX) Pedersen Arne M. (Vanlose DKX), Multiple-units drug dose.
  20. Boswell George A. (Wilmington DE) Myers Melvyn J. (Wilmington DE), N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives.
  21. Uemura Toshinobu (Kishiwada JPX) Okhuma Toshiaki (Osaka JPX) Shinooka Kiyohide (Nishinomiya JPX) Ishikuro Hiroshi (Ikeda JPX) Ueda Yoshio (Koube JPX), Novel drug carrier and pharmaceutical preparation comprising the same.
  22. Theeuwes Felix (Los Altos CA), Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina.
  23. Maratos-Flier Eleftheria, Promotion of eating behavior.
  24. Crissinger Karen D. (Shreveport LA) Tso Patrick (Shreveport LA), Reducing gastrointestinal irritation in infant nutrition.
  25. Evans Ronald M. (La Jolla CA) Swanson Larry (Solana Beach CA) Vale ; Jr. Wylie W. (La Jolla CA) Rosenfeld Michael G. (San Diego CA) Amara Susan G. (La Jolla CA) Brown Marvin R. (Del Mar CA) Rivier Je, Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals.
  26. Riviere Pierre J. M. (9 ; Rue des Arquebusiers 75003 Paris FRX) Pascaud Xavier B. (41 ; Rue de Charenton 75012 Paris FRX) Roman Francois J. (11 ; Alle Pierre-Fresnay 94400 Vitry-sur-Seine FRX) Junien, Use of fedotozine in the treatment of functional states of intestinal obstructions.

이 특허를 인용한 특허 (101)

  1. Cavalla,David; Gristwood,Robert William, 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder.
  2. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  3. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  4. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  5. Pimentel, Mark; Mathur, Ruchi; Kanzer, Steve; Wacher, Vince, Anti-methanogenic compositions and uses thereof.
  6. Farrugia, Gianrico; Friedman, Paul A.; Rajan, Elizabeth; Bruce, Charles J.; Asirvatham, Samuel J.; Levy, Michael J.; Wong Kee Song, Louis-Michel; Bingener-Casey, Juliane; Buttar, Navtej S., Apparatus and methods of inducing weight loss using blood flow control.
  7. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Bulimia treatment.
  8. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Bulimia treatment.
  9. Baron, Alain D.; Brown, Martin R.; Jones, Christopher R. G.; Fineman, Mark S., Chemosensory receptor ligand-based therapies.
  10. Baron, Alain; Brown, Martin R.; Jones, Christopher R. G., Chemosensory receptor ligand-based therapies.
  11. Baron, Alain; Brown, Martin R.; Jones, Christopher R. J., Chemosensory receptor ligand-based therapies.
  12. Quay,Steven C.; Brandt,Gordon, Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity.
  13. Quay,Steven C.; Brandt,Gordon; Kleppe,Mary S.; MacEvilly,Conor J., Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity.
  14. Quay,Steven C.; Brandt,Gordon; Kleppe,Mary S.; MacEvilly,Conor J., Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity.
  15. Quay,Steven C.; Brandt,Gordon; Kleppe,Mary S.; MacEvilly,Conor J., Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity.
  16. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces.
  17. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces.
  18. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces.
  19. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Controlled vagal blockage therapy.
  20. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Controlled vagal blockage therapy.
  21. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Controlled vagal blockage therapy.
  22. Foster, Arthur J.; Erickson, Brian J.; Bierk, Michael D., Custom sized neural electrodes.
  23. Pimentel, Mark; Lin, Henry C., Diagnosis of constipation by analysis of methane concentration.
  24. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Electrode band system and methods of using the system to treat obesity.
  25. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Electrode band system and methods of using the system to treat obesity.
  26. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  27. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  28. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  29. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  30. Fallon, Joan; Heil, Matt, Enzyme delivery systems and methods of preparation and use.
  31. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., GI inflammatory disease treatment.
  32. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., High frequency obesity treatment.
  33. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., High frequency vagal blockage therapy.
  34. Knudson,Mark B.; Wilson,Richard R.; Tweden,Katherine S.; Conrad,Timothy R., Intraluminal electrode apparatus and method.
  35. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Irritable bowel syndrome treatment.
  36. Fallon, Joan M., Method for treating pervasive development disorders.
  37. Fallon, Joan M., Method for treating pervasive development disorders.
  38. Fallon, Joan M., Method for treating pervasive development disorders.
  39. Fallon, Joan M., Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders.
  40. Pimentel, Mark; Lin, Henry C., Method of treating constipation.
  41. Pimentel, Mark; Lin, Henry C., Method of treating constipation-predominant irritable bowel syndrome.
  42. Fallon, Joan M., Method of treating pregnancy-induced hypertension.
  43. Fallon, Joan M., Method of treating proteinuria in pregnancy.
  44. Fallon, Joan M., Method of treating toxemia.
  45. Fallon, Joan M.; Heil, Matthew; Szigethy, James; Fallon, James, Method of treatment of schizophreniform disorder.
  46. Pimentel, Mark; Lin, Henry C., Method of using a probiotic microorganism for the treatment of diarrhea.
  47. Fallon, Joan M.; Heil, Matthew F.; Fallon, James J.; Szigethy, James, Methods and compositions for the treatment of influenza.
  48. Fallon, Joan M., Methods and compositions for the treatment of symptoms of Williams Syndrome.
  49. Fallon, Joan M., Methods and compositions for the treatment of symptoms of prion diseases.
  50. Fallon, Joan M., Methods and compositions for the treatment of symptoms of prion diseases.
  51. Lu,Kuanghui; Pang,Kevin, Methods and reagents for treating glucose metabolic disorders.
  52. Pang, Kevin; Lu, Kuanghui, Methods and reagents for treating glucose metabolic disorders.
  53. Pang, Kevin; Lu, Kuanghui, Methods and reagents for treating glucose metabolic disorders.
  54. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  55. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  56. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  57. Lin, Henry C., Methods for manipulating satiety.
  58. Lin, Henry C., Methods for manipulating satiety.
  59. Lin,Henry C., Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia.
  60. Lin,Henry C., Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia.
  61. Elkashef, Ahmed, Methods for treating conditions caused by higher-than-normal dopaminergic activity in basal ganglia.
  62. Lin, Henry C., Methods for treating irritable bowel syndrome.
  63. Elkashef, Ahmed, Methods for treating schizophrenia.
  64. Lin, Henry C.; Pimentel, Mark, Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions.
  65. Lin, Henry C.; Pimentel, Mark, Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions.
  66. Lin, Henry C.; Pimentel, Mark, Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions.
  67. Pimentel, Mark; Mathur, Ruchi; Chang, Christopher, Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
  68. Pimentel, Mark; Mathur, Ruchi; Chang, Christopher, Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
  69. Pimentel, Mark; Mathur, Ruchi; Chang, Christopher, Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
  70. Fallon, Joan M., Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders.
  71. Lin, Henry C.; Pimentel, Mark, Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth.
  72. Pittner, Richard A.; Young, Andrew A.; Paterniti, Jr., James R., Methods of treating obesity using PYY[3-36].
  73. Fallon, Joan; Heil, Matthew; Szigethy, James; Fallon, James, Methods of treatment of schizophrenia.
  74. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  75. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Nerve blocking for treatment of gastrointestinal disorders.
  76. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Nerve stimulation and blocking for treatment of gastrointestinal disorders.
  77. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Nerve stimulation and blocking for treatment of gastrointestinal disorders.
  78. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Nerve stimulation and blocking for treatment of gastrointestinal disorders.
  79. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Nerve stimulation and blocking for treatment of gastrointestinal disorders.
  80. Donders, Adrianus P.; Weijand, Koen J.; Knudson, Mark B., Neural electrode treatment.
  81. Donders, Adrianus P.; Weijand, Koen J.; Knudson, Mark B., Neural electrode treatment.
  82. Tweden, Katherine S.; Waataja, Jonathan J.; Donders, Adrianus P.; Knudson, Mark B., Neural modulation devices and methods.
  83. Tweden, Katherine S.; Waataja, Jonathan J.; Donders, Adrianus P.; Knudson, Mark B., Neural modulation devices and methods.
  84. Tweden, Katherine S.; Waataja, Jonathan J.; Donders, Adrianus P.; Knudson, Mark B., Neural modulation devices and methods.
  85. Levy, Michael J.; Camilleri, Michael L.; Murray, Joseph A.; Sandborn, William J., Obesity treatment and device.
  86. Levy, Michael J.; Camilleri, Michael L.; Murray, Joseph A.; Sandborn, William J., Obesity treatment and device.
  87. Levy, Michael J.; Camilleri, Michael L.; Murray, Joseph A.; Sandborn, William J., Obesity treatment and device.
  88. Knudson,Mark B.; Wilson,Richard R.; Tweden,Katherine S.; Conrad,Timothy R., Obesity treatment with electrically induced vagal down regulation.
  89. Knudson, Mark B.; Conrad, Timothy R., Pancreatic exocrine secretion diversion apparatus and method.
  90. Knudson, Mark B.; Conrad, Timothy R., Pancreatic exocrine secretion diversion apparatus and method.
  91. Levy, Odile Esther; Jodka, Carolyn M.; Ghosh, Soumitra S.; Parkes, David G.; Pittner, Richard A.; D'Souza, Lawrence J.; Ahn, John S.; Prickett, Kathryn S., Pancreatic polypeptide family motifs and polypeptides comprising the same.
  92. Levy, Odile Esther; Jodka, Carolyn M.; Ghosh, Soumitra S.; Parkes, David G.; Pittner, Richard A.; D'Souza, Lawrence J.; Ahn, John S.; Prickett, Kathryn S.; Roth, Jonathan David; Adams, Sean H., Pancreatic polypeptide family motifs, polypeptides and methods comprising the same.
  93. Levy, Odile Esther; Jodka, Carolyn M.; Ghosh, Soumitra S.; Parkes, David G.; Pittner, Richard A.; D'Souza, Lawrence J.; Ahn, John S.; Prickett, Kathryn S.; Roth, Jonathan David; Adams, Sean H., Pancreatic polypeptide family motifs, polypeptides and methods comprising the same.
  94. Levy, Odile Esther; Jodka, Carolyn M.; Ghosh, Soumitra S.; Parkes, David G.; Pittner, Richard A.; D'Souza, Lawrence J.; Ahn, John S.; Prickett, Kathryn S.; Roth, Jonathan David; Adams, Sean H., Pancreatic polypeptide family motifs, polypeptides and methods comprising the same.
  95. Knudson, Mark B.; Wilson, Richard R.; Tweden, Katherine S.; Conrad, Timothy R., Pancreatitis treatment.
  96. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  97. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  98. Lee, Philip H. J.; Whitehurst, Todd K.; Woods, Carla M., Stimulation of the stomach in response to sensed parameters to treat obesity.
  99. Fallon, Joan M.; Feltenstein, Richard, Use of lactulose in the treatment of autism.
  100. Fallon, Joan M.; Feltenstein, Richard, Use of lactulose in the treatment of autism.
  101. Knudson,Mark B.; Wilson,Richard R.; Tweden,Katherine S.; Conrad,Timothy R., Vagal down-regulation obesity treatment.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로